Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd (600332)

Currency in CNY
21.51
+0.45(+2.14%)
Closed·
Advertisement
Earnings results expected tomorrow
High dividend Yield
600332 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
21.1221.55
52 wk Range
19.3027.62
Key Statistics
Bid/Ask
21.50 / 21.51
Prev. Close
21.06
Open
21.15
Day's Range
21.12-21.55
52 wk Range
19.3-27.62
Volume
13.73M
Average Volume (3m)
9.95M
1-Year Change
-21.3163%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
600332 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
25.80
Upside
+19.94%
Members' Sentiments
Bearish
Bullish
ProTips
Trading at a low earnings multiple
Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy

Analyst Ratings

1 Buy
0 Hold
1 Sell
Ratings:
2 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 25.80
(+19.94% Upside)

Earnings

Latest Release
27/04/2026
EPS / Forecast
1.10 / --
Revenue / Forecast
23.28B / --
EPS Revisions
Last 90 days

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 1.81%
Dividend Yield
4.04%
Industry Median 1.76%
Annualised payout
0.85
Paid annually
5-Years Growth
+9.58%
Growth Streak

Compare 600332 to Peers and Sector

Metrics to compare
600332
Peers
Sector
Relationship
P/E Ratio
11.0x16.0x−0.3x
PEG Ratio
1.230.130.00
Price/Book
0.8x1.5x2.6x
Price / LTM Sales
0.4x1.4x3.1x
Upside (Analyst Target)
20.3%24.7%48.5%
Fair Value Upside
Unlock18.3%6.3%Unlock

Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited engages in the pharmaceutical and healthcare industry in the People’s Republic of China and internationally. The company operates through Modern Chinese Medicine Business, Chemical Pharmaceutical Technology Business, Natural Beverage Business, Pharmaceutical Commercial Business, and Other segments. It is involved in the research, development, manufacturing, and sale of chemical drugs, chemical raw materials, and chemical raw material intermediates; and research, development, production, and sale of health products; and wholesale, retail, and import export of Western medicines, traditional Chinese medicines, and medical devices. The company also offers bio-innovation, consumer health, and medical services; Xiaochaihu granules; Qingkailing and Baoji, Xia Sangju product series; Angong Niuhuang, Zishen Yutai, Xiaoke, Huatuo Zaizao, Zhuangyao Jianshen, and Shujin Jianyao pills; compound Danshen and Naoxinqing tablet series; Banlangen, Compound Banlangen, and Dashen Kouyanqing granules series; and honey-processed Chuanbei and Shedan Chuanbei loquat syrup. In addition, it provides antibacterial and anti-inflammatory drugs, andrological drugs, and analgesics and antipyretics; Wanglaoji herbal tea, Ciningji series, Lixiaoji series, and Yerou coconut milk; and advertising services. Further, the company engages in the medical research industry; technology services industry; leasing and business services; and scientific research and technical services industry. It operates through hospitals, community healthcare facilities, and retail outlets through distributors and agents. The company was formerly known as Guangzhou Pharmaceutical Company Limited and changed its name to Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited in August 2013. Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited was incorporated in 1997 and is based in Guangzhou, China.

Employees
27057
Market
China

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
130.39M8.02%2.75B
Other Institutional Investors
940.72M57.86%19.81B
Public Companies & Retail Investors
554.68M34.12%11.68B
Total
1.63B100.00%34.24B

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Guangzhou Pharmaceutical Holdings Limited45.04%732,305,10315,422,345
Guangzhou China Life Insurance Urban Development Industry Investment Enterprises (LP)4.16%67,576,1831,423,154

People Also Watch

123.07
605499
+0.26%
25.06
000999
+1.83%
28.25
002001
-3.05%
77.10
000408
+2.04%

FAQ

What Is the Guangzhou Baiyunshan (Shanghai: 600332) Share Price Today?

The Guangzhou Baiyunshan stock price today is 21.51 CNY.

What Stock Exchange Does Guangzhou Baiyunshan (600332) Trade On?

Guangzhou Baiyunshan is listed and trades on the Shanghai Stock Exchange.

What Is the Ticker (Stock Symbol) for Guangzhou Baiyunshan?

The stock symbol (also called a 'ticker') for Guangzhou Baiyunshan is "600332."

Does Guangzhou Baiyunshan Pay Dividends? What’s The Current 600332 Dividend Yield?

Yes, 600332 Pays Dividends to its Shareholders. The current Guangzhou Baiyunshan dividend yield is 4.04%.

What Is the Current Guangzhou Baiyunshan Market Capitalisation?

As of today, Guangzhou Baiyunshan (Shanghai: 600332) market cap is 32.46B CNY.

What Is Guangzhou Baiyunshan's (600332) Earnings Per Share (TTM)?

The Guangzhou Baiyunshan EPS is currently 1.81 (Trailing Twelve Months).

When Is the Next Guangzhou Baiyunshan Earnings Date?

Guangzhou Baiyunshan's next earnings report will be released on 21/08/2026.

Is 600332 a Buy or Sell From a Technical Analyst Perspective?

Based on today's Guangzhou Baiyunshan moving averages and other technical indicators, the daily buy/sell signal for 600332 stock is Sell.

How Many Times Has Guangzhou Baiyunshan Stock Split?

Guangzhou Baiyunshan has split 1 times. (See the 600332 stock split history page for full effective split date and price information.)

How Many Employees Does Guangzhou Baiyunshan Have?

Guangzhou Baiyunshan has 27057 employees, based on their latest Companies House report.

What is the current trading status of Guangzhou Baiyunshan (Shanghai: 600332)?

As of 20/08/2026, Guangzhou Baiyunshan (600332) is trading at a share price of 21.51 CNY, with a previous close of 21.06 CNY. The stock has fluctuated within a day range of 21.12 CNY to 21.55 CNY, while its 52-week range spans from 19.30 CNY to 27.62 CNY.

What Is Guangzhou Baiyunshan (600332) Price Target According to Analysts?

The average 12-month price target for Guangzhou Baiyunshan is 25.80 CNY, with a high estimate of 34 CNY and a low estimate of 17.6 CNY. 1 analysts recommend buying the stock, while 1 suggest selling, leading to an overall rating of Buy. The stock has an +19.94% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.